Montag & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.2K | Buy |
138
+1
| +0.7% | +$523 | ﹤0.01% | 516 |
|
|
2025
Q1 | $86.8K | Sell |
137
-2
| -1% | -$1.27K | ﹤0.01% | 518 |
|
|
2024
Q4 | $98.9K | Sell |
139
-644
| -82% | -$458K | ﹤0.01% | 502 |
|
|
2024
Q3 | $823K | Sell |
783
-2
| -0.3% | -$2.1K | 0.04% | 265 |
|
|
2024
Q2 | $825K | Sell |
785
-162
| -17% | -$170K | 0.04% | 252 |
|
|
2024
Q1 | $911K | Buy |
947
+20
| +2% | +$19.3K | 0.05% | 255 |
|
|
2023
Q4 | $814K | Buy |
927
+774
| +506% | +$680K | 0.05% | 254 |
|
|
2023
Q3 | $126K | Hold |
153
| – | – | 0.01% | 439 |
|
|
2023
Q2 | $110K | Sell |
153
-2
| -1% | -$1.44K | 0.01% | 459 |
|
|
2023
Q1 | $127K | Hold |
155
| – | – | 0.01% | 438 |
|
|
2022
Q4 | $112K | Buy |
155
+25
| +19% | +$18K | 0.01% | 437 |
|
|
2022
Q3 | $90K | Hold |
130
| – | – | 0.01% | 453 |
|
|
2022
Q2 | $77K | Hold |
130
| – | – | 0.01% | 469 |
|
|
2022
Q1 | $91K | Hold |
130
| – | – | ﹤0.01% | 482 |
|
|
2021
Q4 | $82K | Hold |
130
| – | – | ﹤0.01% | 510 |
|
|
2021
Q3 | $79K | Hold |
130
| – | – | ﹤0.01% | 502 |
|
|
2021
Q2 | $73K | Hold |
130
| – | – | ﹤0.01% | 504 |
|
|
2021
Q1 | $62K | Hold |
130
| – | – | ﹤0.01% | 529 |
|
|
2020
Q4 | $63K | Buy |
+130
| New | +$63K | ﹤0.01% | 512 |
|